Pharmx Technologies Ltd - Asset Resilience Ratio

Latest as of June 2025: 22.16%

Pharmx Technologies Ltd (PHX) has an Asset Resilience Ratio of 22.16% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Pharmx Technologies Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$4.17 Million
≈ $2.95 Million USD Cash + Short-term Investments

Total Assets

AU$18.82 Million
≈ $13.32 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (1994–2024)

This chart shows how Pharmx Technologies Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PHX total assets.

Liquid Assets Composition Over Time

This chart breaks down Pharmx Technologies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Pharmx Technologies Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$4.17 Million 22.16%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$4.17 Million 22.16%

Asset Resilience Insights

  • Good Liquidity Position: Pharmx Technologies Ltd maintains a healthy 22.16% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Pharmx Technologies Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmx Technologies Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ARTRYA Ltd
AU:AYA
Health Information Services 32.70%
Painchek Ltd
AU:PCK
Health Information Services 55.69%
Intrasense
PA:ALINS
Health Information Services 15.68%
Trivarx Ltd
AU:TRI
Health Information Services 2.55%
HITIQ Ltd
AU:HIQ
Health Information Services 30.25%
Pro Medicus Ltd
AU:PME
Health Information Services 54.64%
Cogstate Ltd
AU:CGS
Health Information Services 54.90%
Echoiq Ltd
AU:EIQ
Health Information Services 11.12%

Annual Asset Resilience Ratio for Pharmx Technologies Ltd (1994–2024)

The table below shows the annual Asset Resilience Ratio data for Pharmx Technologies Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 42.05% AU$12.56 Million
≈ $8.88 Million
AU$29.86 Million
≈ $21.13 Million
-26.60pp
2023-06-30 68.65% AU$25.07 Million
≈ $17.74 Million
AU$36.52 Million
≈ $25.84 Million
+34.51pp
2022-06-30 34.14% AU$10.50 Million
≈ $7.43 Million
AU$30.77 Million
≈ $21.77 Million
+13.47pp
2021-06-30 20.67% AU$6.48 Million
≈ $4.58 Million
AU$31.35 Million
≈ $22.18 Million
+8.55pp
2020-06-30 12.11% AU$2.32 Million
≈ $1.64 Million
AU$19.18 Million
≈ $13.57 Million
-3.40pp
2019-06-30 15.51% AU$2.33 Million
≈ $1.65 Million
AU$15.04 Million
≈ $10.64 Million
-9.69pp
2018-06-30 25.20% AU$4.97 Million
≈ $3.52 Million
AU$19.73 Million
≈ $13.96 Million
-15.79pp
2017-06-30 40.99% AU$8.10 Million
≈ $5.73 Million
AU$19.76 Million
≈ $13.98 Million
+38.68pp
1995-06-30 2.31% AU$246.00K
≈ $174.06K
AU$10.64 Million
≈ $7.53 Million
-3.14pp
1994-06-30 5.45% AU$796.00K
≈ $563.22K
AU$14.61 Million
≈ $10.34 Million
--
pp = percentage points

About Pharmx Technologies Ltd

AU:PHX Australia Health Information Services
Market Cap
$36.06 Million
AU$50.96 Million AUD
Market Cap Rank
#23214 Global
#868 in Australia
Share Price
AU$0.09
Change (1 day)
-3.41%
52-Week Range
AU$0.08 - AU$0.17
All Time High
AU$0.17
About

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more